Essential Imaging Tools

Slides:



Advertisements
Similar presentations
WATCHMAN™ Left Atrial Appendage Closure Device
Advertisements

Disclosure Information Devices for ASD&PFO Closure: Amplatzer Devices As a faculty member for this program, I disclose the following relationships with.
WATCHMAN™ Device Implant Overview
WATCHMAN™ LAA Closure Technology
Left atrial appendage occlusion: Ready for prime time? David Hildick-Smith Sussex Cardiac Centre Brighton, UK.
Transcatheter ASD closure, sans X-rays Peter Ewert MD Robert Beekman MD.
C E N T E R F O R C O N G E N I T A L H E A R T D I S E A S E S T U T T G A R T Presenter disclosure information name: Frank Uhlemann In the last 12 month.
Antithrombotic and Thrombolytic Therapy for Valvular Disease Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Emerging Applications for Transseptal Left Heart.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Imaging the Left Atrial Appendage Prior to, During,
Why Treat Patent Forman Ovale Clifford J Kavinsky, MD, PHD Professor of Medicine and pediatrics Associate Director, Center for Congenital and Structural.
Antithrombotic and Thrombolytic Therapy for Valvular Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Does the Left Atrial Appendage Morphology Correlate.
Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Catheter-induced linear lesions in theleft atrium.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Integrated 3D Echo-X Ray to Optimize Image Guidance.
Disclosure Statement of Financial Interest Saibal Kar, MD, FACC
Post-FDA Approval, Initial US Clinical Experience with Watchman Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation Vivek Y. Reddy.
Prof. Dr. med. H. R. Figulla Director at the University Hospital Jena
Post-FDA Approval, Initial US Clinical Experience with Watchman Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation Vivek Y. Reddy.
Management of Patients on Chronic Oral Anticoagulant Therapy
Trans-Catheter Aortic Pseudo-Aneurysm Repair
Update on the Watchman Device CRT 2010 Washington, DC
Update on PFO stents Mark Reisman, M.D., F.A.C.C.
LAAO with Watchman Device Post-Procedure Best Practices
CRT 2017: Putting LAA closure in the age of DOACs into perspective
Successful retrieval of embolized atrial septal defect and patent foramen ovale closure device using novel coronary wire trap (CWT) technique. Alireza.
Case Demonstration: MitraClip Edge-to–Edge Repair
How to Screen Patients for LAAC
David R. Holmes, Jr., M.D. Mayo Clinic, Rochester
Carotid Artery Stenting Predictors of procedural and clinical success
CRT Washington, D.C. February 23, 2010 Tim A. Fischell, M.D. FACC
A Primer of LAA Closure: and Pattern Recognition
Ramon Quesada, MD, FACP,FACC, FSCAI,
2 A Cardiology Department, University of Athens
Timing of Intervention in Mitral Stenosis
Transcatheter Mitral Valve Repair Tips and tricks for access
Kyle D Buchanan, MD MedStar Washington Hospital Center
Percutaneous Device Occlusions for Left Atrial Appendage (LAA)
A Primer of LAA Closure: and Pattern Recognition
Fractional Flow Reserve Workshop
Patent Foramen Ovale and Stroke
Transesophageal Echocardiography
Volume 12, Issue 7, Pages (July 2015)
Left atrial appendage closure: A new technique for clinical practice
Osami Honjo, MD, PhD, Vivek Rao, MD 
Tricuspid Valve Repair for Ebstein's Anomaly
Niyada Naksuk et al. JACEP 2016;2:
Niyada Naksuk et al. JACEP 2016;2:
Transesophageal Echocardiography
the Cardiovascular System I
Surgical Implantation of the Acorn Cardiac Support Device
The Standard Maze-III Procedure
HeartRhythm Case Reports
Repair of primum ASD with cleft mitral valve
Case-Based Discussion Regarding Challenges in Patient Selection and Procedural Planning in Left Atrial Appendage Occlusion  Sidakpal S. Panaich, MD, Thomas.
Niyada Naksuk et al. JACEP 2016;2:
Hidehiko Hara et al. JIMG 2008;1:92-93
The standard maze-III procedure1 1 This article was previously published in Operative Techniques in Thoracic and Cardiovascular Surgery 5:2–22, 2000 (doi:
Termination of anticoagulation therapy at 45 days after concomitant atrial fibrillation catheter ablation and left atrial appendage occlusion resulting.
(A–D) Preprocedural transoesophageal echocardiography (TEE) imaging—left atrial appendage (LAA) anatomy and dimensions should be studied with the transducer.
Air emboli during the procedure of transcatheter left atrial appendage closure  Shuang Li, MD, Wei Chen, MD, PhD, Shuang Li, MD, Dongdong Zhao, MD, PhD,
Sagit Ben Zekry et al. JIMG 2008;1:
Device-specific CT-based LAA occluder size selection.
Left Atrial Appendage Occlusion for The Unmet Clinical Needs of Stroke Prevention in Nonvalvular Atrial Fibrillation  David R. Holmes, MD, Mohamad Alkhouli,
(A-B) the ACP device consists of a lobe and a disk connected by a short, flexible waist. (A-B) the ACP device consists of a lobe and a disk connected by.
Bahij Kreidieh, MD, Miguel Valderrábano, MD, FHRS 
Nina C. Wunderlich et al. JIMG 2015;8:
General morphology classification of left atrial appendage (LAA) as determined by cardiac CT. LAA can be classified into four types: (A) chicken wing type—with.
Jacqueline Saw, and Mathieu Lempereur JCIN 2014;7:
Presentation transcript:

Essential Imaging Tools for LAA Closure Steven A. Goldstein MD FACC, FASE MedStar Heart Institute Washington Hospital Center Saturday, February 18, 2017

financial relationships DISCLOSURE I have N O relevant financial relationships

LAA Anatomy

LA-Appendage Anatomy Highly variable structure (size and shape) Long, hook-like true diverticulum of LA Lies within the pericardium Orifice is usually elliptical (not round) Lies in more than 1 imaging plane Often multi-lobed

Left Atrial Appendage Dimensions (Silicone casts from 11 specimens) Mean Range SD Length Os long diameter Os short diameter 44.9 mm 17.4 mm 10.9 mm 27-60 mm 10-24 mm 5-20 mm 9.6 mm 4 mm 4.2 mm Su (Royal Brompton, London – National Heart and Lung Institute) Heart 2008;94:1166-1170

Width = 2.9 cm Depth = 5.6 cm

LAA Orifice Classification Oval Foot-like Triangular Tear drop Round 68.9% 10% 7.7% 5.6%

Left Atrial Appendage Lobes Autopsy study (n=500) 2 lobes 3 lobes 1 lobe 4 lobes 54% 23% 20% 3% Veinot Circulation 1997;96:3112-3115

LA-Appendage Closure Role of TEE Identify all the lobes of the LAA Measure the size of the LAA ostium Look for thrombus/ dense “smoke” Look for atrial septal anatomy: ASD, PFO Identify other potential cardiac sources Provide guidance for transseptal puncture of embolism (eg atrial septal aneurysm, aortic debris)

Septation tissue between lobes can mimic a thrombus

Multi-Lobed LA-Appendage

Multilobed Atrial Appendage

LAA Anatomy/Assessment LAA size, shape Number of lobes Measure ostium at 0º, 45º, 90º, 135º Measure depth (length) of LAA From LCx to a point 2 cm from limbus tip From top of MV annulus “ “ “ “ “

LAA Anatomy/Assessment Maximum LAA ostium and LAA depth Max LAA ostium size should be ≥17 mm LAA length should be equal to or greater measurements determine size selection ≤ 31 mm to accommodate device sizes than the ostium

LAA Anatomy/Assessment Device Sizing Maximum LAA Ostium (mm) Device Size (mm) 17 – 19 20 – 22 23 – 25 26 – 28 29 – 31 21 24 27 30 33

4 Main Morphologies of LAA Cactus Windsock Cauliflower Chicken Wing more likely embolic event Di Biase J Am Coll Cardiol 2012; 60:531-538

Windsock Chicken wing Cauliflower Limited length More complex internal characteristics One dominant lobe Sufficient length Sharp bend in dominant lobe

Prevalence of Prior Stroke/TIA According to LAA Morphology Stroke rate (%) Di Biase J Am Coll Cardiol 2012; 60:531-538

Case 21 year-old woman

Chicken Wing

Case

Case

Case

ER - 88 year-old man Chronic atrial fibrillation Cardioversion  reverted to atrial fibrillation Coumadin problematic  “easy bruising” Referred to Watchman Trial Pre-procedure TEE . . . .

“Hammerhead” shape of LA-appendage

Case Tuesday, Feb. 14, 2017

Very basal “cul-de-sac” (extra lobe) Case 54 Very basal “cul-de-sac” (extra lobe)

Very basal “cul-de-sac” (extra lobe) Case 54 Very basal “cul-de-sac” (extra lobe)

Case 54

Look for Thrombi

Case Thrombus in LAA

Measurements 0º 45º 90º 135º

Landing Zone

Transseptal Puncture

Site Specific Transseptal Puncture for Various Interventions Transseptal PFO closure (higher crossing site for medial leaks; lower site for lateral leaks) Paravalve leak closure LVAD placement Hemodynamic studies LA-appendage closure Pulmonary vein interventions Alkhouli J Am Coll Cardiol 2016;9(24):2465-80

Transseptal Crossing Preferred crossing location is posterior Bicaval and short-axis views useful X-plane useful and inferior Inferior on short-axis view Posterior on bicaval view

The value of X-plane (biplane  2 orthogonal views) Guidance of Transseptal Puncture The value of X-plane (biplane  2 orthogonal views)

Case

Transseptal Puncture for Watchman Too anterior Slightly more posterior

Case BH - 76 year-old woman Watchman LAA closure Case 16

BH - 76 year-old woman Longstanding, chronic atrial fibrillation Multiple cardioversions  failed Referred for Protect – Watchman Trial

Successful placement of 21 mm LA-appendage occluder device with TEE guidance

Width = 1.2 cm Length = 2.4 cm

0° 45° 90° 135° Prior to final deployment, check position in 4 views: 0° 45° 90° 135°

LAA-occluder adjacent to L-pulmonary vein

Device Release Criteria P.A.S.S. Position – device is at ostium of LAA Anchor – fixation anchors engaged Size – device compressed 8-20% Seal - device spans ostium - device is stable (tug test) - all lobes of LAA covered - absence of peri-leak

Device should be at or just distal to the LA-appendage ostium Device Release Criteria Device should be at or just distal to the LA-appendage ostium

Peri-Leak

Iatrogenic ASD

LAA Occlusion Anticoagulation Post-Procedure Warfarin and aspirin x 45 days TEE at 45 days If no or minimal (≤ 5 mm) peridevice flow stop warfarin, start clopidogrel (75 mg), continue aspirin until 6 mos post procedure

Case

PR - 71 year-old man Watchman procedure performed Successful insertion Refused anticoagulation, despite protocol

The End